Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com  x.com 

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com 

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras Systems offers the fastest AI inference chip available, a single wafer-sized processor with the model's memory on the chip, running inference several times faster than GPU systems. It has a $25.4B backlog, about 30x this year's revenue, partnerships with OpenAI, AMD and AWS, and no exposure to rising HBM prices. Concerns: a 14.2% GAAP gross margin, about $600M of free cash flow burned in the first half, roughly 80% of backlog tied to OpenAI, and about 171M shares unlocking in November. … Show more

Cerebras may be the only company willing to stitch together a true high-speed solution. If so, it retains upside optionality from high-speed pricing and gains a first-mover advantage. x.com  x.com 

Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.com 

Cerebras and its customers likely accounted for many of the chip limitations alleged in the short report, so the report may be wrong. This is a suspicion without specific insight. Short interest rose 40.7% into the report to 19.86 million shares, or 8.4% of float. x.com  x.com 

Cerebras is a speculative, high-risk, high-reward bet on faster inference that could make its $44B market cap a multi-bagger if it works. Putting the whole processor and memory on one wafer wins on speed, not cheaper memory, since on-chip SRAM costs more per bit than HBM; Nvidia is answering via Groq. G42 and MBZUAI were 86% of 2025 revenue, but the ramp ahead is tied to OpenAI. The $160s level has held as support four times since the IPO. Size it to one's capital-preservation goals. x.com 

Cerebras is an unattractive stock to hold now, even though ultrafast speed is a feature companies would happily pay for. Controversy over OpenAI's ultrafast running on Nvidia chips, the share lockup expiration and insider selling outweigh the chance that OpenAI's next 6.1 Sol ultrafast actually runs on Cerebras chips. x.com 

Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.com